Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene
PDF

Case Report

Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene

J Clin Res Pediatr Endocrinol 2015;7(3):242-248 DOI: 10.4274/jcrpe.2067
, , , , , ,
PDF
Permissions

Abstract

Testotoxicosis is a rare disorder which presents as isosexual peripheral precocious puberty in males. Despite the pattern of autosomal dominant inheritance, sporadic cases also may occur. Due to activating mutation in luteinizing hormone (LH))/choriogonadotropin receptor (LHCGR) gene, early virilization and advancement in bone age are common with increased serum testosterone levels above adult ranges, despite low LH and follicular-stimulating hormone (FSH) levels. There are different treatment regimens, such as combination of bicalutamide (antiandrogen agent) and a third-generation aromatase inhibitor, that are reported to be well-tolerated and successful in slowing bone age advancement and preventing progression of virilization. We report here two patients who presented with peripheral precocious puberty and an activating mutation in the LHCGR gene: one with a family history and previously determined mutation and the other without family history and with a novel mutation (c.830G>T). Combination of bicalutamide+anastrozole was ineffective in slowing pubertal progression and bone age. Short-term results were better with ketoconazole.

Keywords: Testotoxicosis, microlithiasis, anastrozole, bicalutamide, cyproterone acetate, ketoconazole

Read the full text

2 sections · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.